Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E2 in the spinal cord

[1]  A. Kawabata.  Prostaglandin E2 and pain--an update. , 2011, Biological & pharmaceutical bulletin.

[2]  G. Dussor,et al.  Central modulation of pain. , 2010, The Journal of clinical investigation.

[3]  E. Ewan,et al.  Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat , 2010, Brain Research.

[4]  R. Quirion,et al.  Injured nerve-derived COX2/PGE2 contributes to the maintenance of neuropathic pain in aged rats , 2010, Neurobiology of Aging.

[5]  M. Angst.  Intrathecal cyclooxygenase inhibitors in humans: don't throw in the towel! , 2010, Anesthesiology.

[6]  T. Houle,et al.  Effects of Intrathecal Ketorolac on Human Experimental Pain , 2010, Anesthesiology.

[7]  T. Yaksh,et al.  Role of Spinal Cyclooxygenase in Human Postoperative and Chronic Pain , 2010, Anesthesiology.

[8]  M. Tagen,et al.  Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection. , 2009, Biomedical chromatography : BMC.

[9]  V. Hruby,et al.  Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors. , 2009, Brain : a journal of neurology.

[10]  L. Weaver,et al.  Blockade of the 5‐HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury , 2009, Journal of neuroscience research.

[11]  Kazunari Nakao,et al.  Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. , 2008, European journal of pharmacology.

[12]  I. Chessell,et al.  Localisation and modulation of prostanoid receptors EP1 and EP4 in the rat chronic constriction injury model of neuropathic pain , 2007, European journal of pain.

[13]  Louis P. Vera-Portocarrero,et al.  Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways , 2007, Pain.

[14]  S. Drechsler,et al.  The neuronal 5-HT3 receptor network after 20 years of research--evolving concepts in management of pain and inflammation. , 2007, European journal of pharmacology.

[15]  C. Woolf,et al.  Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  Q. Smith,et al.  Brain Uptake of Nonsteroidal Anti-Inflammatory Drugs: Ibuprofen, Flurbiprofen, and Indomethacin , 2006, Pharmaceutical Research.

[17]  S. Narumiya,et al.  Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. , 2005, The Journal of clinical investigation.

[18]  T. Vanderah,et al.  Cholecystokinin in the Rostral Ventromedial Medulla Mediates Opioid-Induced Hyperalgesia and Antinociceptive Tolerance , 2005, The Journal of Neuroscience.

[19]  M. Heinricher,et al.  Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. , 2004, Journal of neurophysiology.

[20]  Rie Suzuki,et al.  Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury , 2004, Brain Research.

[21]  L. Weaver,et al.  The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury , 2004, Pain.

[22]  M. Heinricher,et al.  Nociceptive facilitating neurons in the rostral ventromedial medulla , 2004, Pain.

[23]  A. Dickenson,et al.  Does a Single Intravenous Injection of the 5HT3 Receptor Antagonist Ondansetron Have an Analgesic Effect in Neuropathic Pain? A Double-Blinded, Placebo-Controlled Cross-Over Study , 2003, Anesthesia and analgesia.

[24]  J. Eisenach,et al.  Four PGE2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation , 2003, Experimental Neurology.

[25]  G. Gebhart,et al.  Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla , 2003, Pain.

[26]  G. McCleane.  The Cholecystokinin Antagonist Proglumide Enhances the Analgesic Effect of Dihydrocodeine , 2003, The Clinical journal of pain.

[27]  T. Yaksh,et al.  Phase I safety assessment of intrathecal ketorolac , 2002, Pain.

[28]  H. Schaible,et al.  Spinal Prostaglandins Are Involved in the Development But Not the Maintenance of Inflammation-Induced Spinal Hyperexcitability , 2001, The Journal of Neuroscience.

[29]  T. Vanderah,et al.  Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin , 2001, Pain.

[30]  C. Woolf,et al.  Direct Activation of Rat Spinal Dorsal Horn Neurons by Prostaglandin E2 , 2001, The Journal of Neuroscience.

[31]  T. Vanderah,et al.  Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance , 2001, The Journal of Neuroscience.

[32]  A. Dickenson,et al.  An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT3 receptors in the anaesthetized rat , 2000, Pain.

[33]  F. Porreca,et al.  Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat , 2000, Pain.

[34]  N. Davies,et al.  Choosing the Right Nonsteroidal Anti-Inflammatory Drug for the Right Patient , 2000, Clinical pharmacokinetics.

[35]  P. Dubey,et al.  Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blinded study. , 1999, Anesthesia and analgesia.

[36]  H. Schaible,et al.  The intraspinal release of prostaglandin E2 in a model of acute arthritis is accompanied by an up-regulation of cyclo-oxygenase-2 in the spinal cord , 1999, Neuroscience.

[37]  M. Goppelt‐Struebe,et al.  Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis , 1998, Inflammation Research.

[38]  G. McCleane.  The Cholecystokinin Antagonist Proglumide Enhances the Analgesic Efficacy of Morphine in Humans with Chronic Benign Pain , 1998, Anesthesia and analgesia.

[39]  W. Neuhuber,et al.  Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord , 1998, Journal of Neuroimmunology.

[40]  S. Giblett,et al.  Prostanoids synthesized by cyclo‐oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability , 1997, British journal of pharmacology.

[41]  M. Trevethick,et al.  The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia , 1997, Neuroscience.

[42]  A. Pertovaara,et al.  Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats , 1996, Neuroscience Letters.

[43]  M. Goppelt‐Struebe,et al.  Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammation , 1996, FEBS letters.

[44]  J. Stamford.  Descending control of pain. , 1995, British journal of anaesthesia.

[45]  A. Malmberg,et al.  The effect of morphine on formalin‐evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats , 1995, British journal of pharmacology.

[46]  O. Hayaishi,et al.  Characterization of EP‐receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice , 1994, British journal of pharmacology.

[47]  H. Fields,et al.  Serotonin immunoreactivity is contained in one physiological cell class in the rat rostral ventromedial medulla , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  T. Hökfelt,et al.  Cholecystokinin in Mammalian Primary Sensory Neurons and Spinal Cord: In Situ Hybridization Studies in Rat and Monkey , 1993, The European journal of neuroscience.

[49]  P. Mantyh,et al.  Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate- CCK analgesic interactions , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[51]  A. Malmberg,et al.  Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. , 1992, Science.

[52]  M. Zhuo,et al.  Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. , 1992, Journal of neurophysiology.

[53]  C. Woolf,et al.  Dynamic alterations in the cutaneous mechanoreceptive fields of dorsal horn neurons in the rat spinal cord , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  S. Iversen,et al.  The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. , 1990, European journal of pharmacology.

[55]  A. Björklund,et al.  Endogenous Release of Neuronal Serotonin and 5‐Hydroxyindoleacetic Acid in the Caudate‐Putamen of the Rat as Revealed by Intracerebral Dialysis Coupled to High‐Performance Liquid Chromatography with Fluorimetric Detection , 1988, Journal of neurochemistry.

[56]  J. Glowinski,et al.  [Chronic refractory pain in cancer patients. Value of the spinal injection of lysine acetylsalicylate. 60 cases]. , 1987, Presse medicale.

[57]  A. Basbaum,et al.  Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs , 1987, Neuroscience.

[58]  P. Mantyh,et al.  Evidence for cholecystokinin-like immunoreactive neurons in the rat medulla oblongata which project to the spinal cord , 1984, Brain Research.

[59]  I. Hentall,et al.  The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  L. Watkins,et al.  Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. , 1983, Science.

[61]  J. Rehfeld,et al.  Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. , 1978, The Journal of biological chemistry.

[62]  T. Yaksh,et al.  Chronic catheterization of the spinal subarachnoid space , 1976, Physiology & Behavior.

[63]  H. Kusuhara,et al.  Active efflux across the blood-brain barrier: Role of the solute carrier family , 2011, NeuroRX.

[64]  A. Nakamura,et al.  Etodolac attenuates mechanical allodynia in a mouse model of neuropathic pain. , 2009, Journal of pharmacological sciences.

[65]  S. Kimura,et al.  Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice. , 2009, Journal of pharmacological sciences.

[66]  M. Heinricher,et al.  Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. , 2001, Journal of neurophysiology.

[67]  A I Basbaum,et al.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.